The top 100 stock
market authors
selected for publication
market authors
selected for publication
Forest Laboratories Inc. (FRX) ()
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Forest Laboratories Inc. (FRX) by latest | most commented
- Healthcare: Branded Pharma Out, Diagnostics / Generics In
- Forest Labs: Positive Top-Line Data on Ceftaroline
- 30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
- Forest Labs: Concerned About Pipeline
- S&P 500's Top Decile Economic Margin Companies
- 30 Attractive Companies Under $30: Fidelity's Low Priced Stock Fund Part II
- Sell in May and Go Away? No Way
- Cypress Bioscience: Investing in Pain
- Top Ten S&P 500 Value Score Stocks
- Pharmaceutical Stocks Remain a Buy
- 20 Stocks with High Net Cash
- FDA, Clinical Trial Calendar Updates: Actelion, Merck Discontinue Partnership
- Rentec Ratchets Up Positions in Q408
- Thursday Options Update: FRX, CSX, RIMM & BIIB
- The S&P 500's Strongest Balance Sheets
- Pharma Investments Are Starting to Pay Off
- Updates to FDA and Clinical Trial Calendars
- Biopharma: Instead of M&A, Think P&A
- Testing Benjamin Graham's Investment Criteria
- What We View as Bruce Berkowitz's Best Holdings
- Bullish Thesis for Biotech Remains Intact
- Forest Laboratories: Perhaps the Next Consolidator?
- Trading FDA Decisions: Cypress Bioscience Soars, A Trio of Buys
- Ben Graham Approach to Investing Outperforms the Markets
- Companies in Shape, and Looking Good...
- Stocks Affected by FDA Calendar of Expected Decision Dates
- Hedge Fund Portfolio Tracking: Renaissance Technologies (Jim Simons), Q3 2008
- 9 Possible Pharma Deals for 2009
- 4 Drug Stocks Trading Above Moving Averages
- Five Healthcare Stocks Positioned for a Happy New Year
- Updated FDA Calendar: Cypress Bioscience Looks Like a Buy
- Cytori Therapeutics and Cypress Bio: Two Buys Based on Positive Trial Results
- Sell Risk, Buy Pharma
- What Are Some of the Best Hedge Fund Managers Doing?
- Berkowitz, Rodriguez and Pabrai: Examining Q3 Filings
- Recessionary Equity Strategies: Having It All
- Backlog of Decisions Is Building at the FDA
- Six Healthcare Stocks at Sale Prices
- Recessionary Equity Strategies: Flight to Quality
- FDA Action Before Year End
- Options Trader: Outlook for a Testy Tuesday
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largest
increase in followers
in the last 7 days-
1
David Fry
-
2
Philip Davis
-
3
Bill Gross
-
4
Tyler Durden
-
5
TraderMark
Fastest Climbers » -
1
-
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
